Baldwin Investment Management, LLC Novo Nordisk A S Transaction History

Baldwin Investment Management, LLC

$810 Million
Q1 2025

A detailed history of Baldwin Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Baldwin Investment Management, LLC holds 22,315 shares of NVO stock, worth $1.54 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

22,315

Previous 21,740 2.64%

Holding current value

$1.54 Million

Previous $1.87 Million 17.17%

% of portfolio

0.19%

Previous 0.51%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$69.3 - $90.95 $39,847 - $52,296	575 Added 2.64%	22,315 $1.55 Million
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $37,400 - $52,817	-440 Reduced 1.98%	21,740 $1.87 Million
Q2 2024 Jul 30, 2024	SELL	$122.71 - $146.91 $56,569 - $67,725	-461 Reduced 2.04%	22,180 $3.17 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $132,232 - $176,016	-1,295 Reduced 5.41%	22,641 $2.91 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $17,556 - $21,090	200 Added 0.84%	23,936 $2.48 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.08 Million - $2.37 Million	11,868 Added 100.0%	23,736 $2.16 Million
Q2 2023 Aug 01, 2023	SELL	$155.98 - $172.65 $48,509 - $53,694	-311 Reduced 2.55%	11,868 $1.92 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $38,353 - $50,613	-374 Reduced 2.98%	12,179 $1.65 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $37,445 - $45,953	-393 Reduced 3.04%	12,553 $1.25 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $47,940 - $58,540	-500 Reduced 3.72%	12,946 $1.45 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $24,222 - $30,344	358 Added 2.74%	13,446 $1.13 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $32,188 - $36,393	-480 Reduced 3.54%	13,088 $882,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $6,389 - $7,380	-100 Reduced 0.73%	13,568 $948,000
Q2 2020 Jul 27, 2020	BUY	$58.54 - $67.94 $10,888 - $12,636	186 Added 1.38%	13,668 $895,000
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $47,234 - $61,864	-955 Reduced 6.61%	13,482 $812,000
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $14,309 - $16,082	301 Added 2.13%	14,437 $746,000
Q2 2019 Aug 06, 2019	BUY	$46.79 - $52.47 $23,395 - $26,235	500 Added 3.67%	14,136 $722,000
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $20,770 - $23,625	500 Added 3.81%	13,636 $628,000
Q2 2018 Aug 15, 2018	BUY	$44.29 - $50.42 $225,879 - $257,142	5,100 Added 63.46%	13,136 $606,000
Q1 2018 May 11, 2018	SELL	$48.49 - $58.14 $2,133 - $2,558	-44 Reduced 0.54%	8,036 $396,000
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $3,127 - $3,740	76 Added 0.95%	8,080 $389,000
Q2 2017 Aug 08, 2017	BUY	N/A	8,004	8,004 $343,000

Others Institutions Holding NVO

# of Institutions

1,826

Shares Held

339M

Call Options Held

12M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $156B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.

Account

Baldwin Investment Management, LLC Novo Nordisk A S Transaction History